Lfb Biomedicaments Sustainability Reports
LFB Biomedicaments develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins. The company focuses on treating serious and rare diseases across immunology, hemostasis, and intensive care fields.
Sector: Manufacturing
Country: France
Exchange: Unlisted
LEI: 969500WARKTWUKB30C84
No reports are currently available in our catalogue.